$0.2817
-0.0057-1.98%
Last update: Oct 23, 7:47 PM
Mereo BioPharma Group PLC (MREO) Stock Price, Quote, News & History
MREONASDAQ
Ultragenyx stock closed 42% lower on Monday as from Phase 3 studies for setrusumab in OI revealed no statistical significance.
You can purchase shares of Mereo BioPharma Group (NASDAQ:MREO) through any online brokerage.
Other companies in Mereo BioPharma Group’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Mereo BioPharma Group has a consensus price target of $4.58.
The stock price for Mereo BioPharma Group (NASDAQ: MREO) is $0.28 last updated October 23, 2026 at 7:47 PM EDT.
There are no upcoming dividends for Mereo BioPharma Group.
Mereo BioPharma Group does not have any upcoming earnings scheduled.
There is no upcoming split for Mereo BioPharma Group.
Mereo BioPharma Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare...
